Published in Pancreas on March 01, 2013
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Diabetes, pancreatic cancer, and metformin therapy. Front Physiol (2014) 0.92
Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy. PLoS One (2014) 0.92
Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ (2015) 0.88
Is diabetes mellitus a risk factor for pancreatic cancer? World J Gastroenterol (2013) 0.81
Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study. Am J Gastroenterol (2014) 0.81
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer. J Natl Compr Canc Netw (2014) 0.79
High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose. Biomed Rep (2013) 0.78
Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol (2016) 0.78
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Pancreas (2016) 0.78
Diabetes mellitus and pancreatic cancer: why the association matters? Pancreas (2013) 0.78
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. Br J Cancer (2016) 0.75
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Diagnosis and classification of diabetes mellitus. Diabetes Care (2008) 8.16
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology (2005) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg (1993) 1.62
Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med (1992) 1.47
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology (2001) 1.35
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res (1995) 1.19
The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care (2004) 1.07
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Beta-cell function in pancreatic adenocarcinoma. Pancreas (1994) 0.95
Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients. Pancreas (2003) 0.94
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol (2011) 2.17
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg (2008) 2.04
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell (2005) 2.01
Severe acute pancreatitis. JAMA (2004) 2.00
Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas (2003) 1.96
Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut (2012) 1.67
Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64
EUS-guided pancreatic duct intervention: outcomes of a single tertiary-care referral center experience. Gastrointest Endosc (2013) 1.64
Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Clin Cancer Res (2006) 1.61
IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol (2006) 1.59
Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block. Am J Gastroenterol (2007) 1.58
Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol (2004) 1.57
Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology (2007) 1.56
Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas (2003) 1.56
Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol (2009) 1.55
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49
Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol (2011) 1.48
Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology (2007) 1.45
Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci (2011) 1.43
Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg (2005) 1.42
Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol (2009) 1.39
Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol (2004) 1.36
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35
Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology (2012) 1.34
EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc (2005) 1.26
IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol (2010) 1.22
Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer (2011) 1.20
Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis". Am J Gastroenterol (2009) 1.20
Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas (2011) 1.20
Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas (2009) 1.20
Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors. Clin Gastroenterol Hepatol (2005) 1.16
Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer. Pancreatology (2005) 1.16
Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases. Gastrointest Endosc (2008) 1.16
Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol (2003) 1.14
Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res (2006) 1.11
IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol (2012) 1.11
Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut (2013) 1.10
Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology (2010) 1.08
Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia (2004) 1.08
Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc (2007) 1.08
Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol (2009) 1.08
Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology (2013) 1.07
Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas (2003) 1.06
Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis (2009) 1.06
Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Am J Gastroenterol (2013) 1.05
Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol (2008) 1.04
Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol (2010) 1.04
Minimally invasive techniques in pancreatic necrosis. Pancreas (2009) 1.03
Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep (2012) 1.03
Optimising corticosteroid treatment for autoimmune pancreatitis. Gut (2007) 1.01
Acute pancreatitis in patients with Crohn's disease: clinical features and outcomes. Inflamm Bowel Dis (2005) 0.99
Autoimmune pancreatitis. Gastroenterol Clin North Am (2008) 0.99
Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol (2009) 0.99
Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol (2009) 0.99
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology (2014) 0.98
Autoimmune pancreatitis. Curr Gastroenterol Rep (2005) 0.98
Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Management of pancreatic masses. Pancreas (2005) 0.97
Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise. Gastroenterology (2006) 0.97
Autoimmune pancreatitis, Part II: the relapse. Gastroenterology (2008) 0.95
New-onset diabetes in pancreatic cancer: a study in the primary care setting. Pancreatology (2012) 0.95
Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol (2009) 0.95
IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. Int J Urol (2012) 0.95
Corticosteroid treatment for autoimmune pancreatitis. Gut (2009) 0.95
Eosinophilia and allergic disorders in autoimmune pancreatitis. Am J Gastroenterol (2010) 0.94
Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol (2008) 0.93
Calcifying obstructive pancreatitis: a study of intraductal papillary mucinous neoplasm associated with pancreatic calcification. Clin Gastroenterol Hepatol (2004) 0.93
Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis. Am J Gastroenterol (2009) 0.93
Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR Am J Roentgenol (2009) 0.92
Conservative management of infected necrosis complicating severe acute pancreatitis. Am J Gastroenterol (2003) 0.91
Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas (2011) 0.91
Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature. Pancreas (2016) 0.91
Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology (2014) 0.90
Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer. Pancreatology (2008) 0.90
Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas (2014) 0.88
Clinical hypothyroidism in autoimmune pancreatitis. Pancreas (2010) 0.88
Pediatric pancreatic EUS-guided trucut biopsy for evaluation of autoimmune pancreatitis. Gastrointest Endosc (2013) 0.87
The effect of age on hospital outcomes in severe acute pancreatitis. Pancreatology (2008) 0.87
Autoimmune pancreatitis. Curr Opin Gastroenterol (2008) 0.87
Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol (2009) 0.87
Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas (2014) 0.87
Protease inhibitors in acute pancreatitis: lessons from the bench and failed clinical trials. Gastroenterology (2005) 0.86
Organ failure as an indicator of severity of acute pancreatitis: time to revisit the Atlanta classification. Gastroenterology (2005) 0.86
Can histopathology be the "Gold Standard" for diagnosing autoimmune pancreatitis? Gastroenterology (2005) 0.86
The diagnosis of autoimmune pancreatitis: a Western perspective. Pancreas (2009) 0.84
Diagnosis and treatment of autoimmune pancreatitis. Curr Opin Gastroenterol (2010) 0.84